HemoCath is redefining the standard of cardiac care
Embedded Files
About HemoCath
About HemoCath
HemoCath is uniquely positioned at the convergence of MedTech and Healthcare AI, commercializing the HemoDynamix™ AI Platform — a comprehensive, scalable solution with the potential to become a new standard of care in acute heart failure management.
Our Mission
Our Mission
Our core mission is to transform acute heart failure management from a reactive, crisis-driven response into proactive, predictive care that sets a new global standard of cardiac care.
Leadership
Leadership
Our leadership team brings over 120 years of combined experience in medicine, engineering, commercialization, and corporate finance — with a proven record of turning breakthrough innovations into market successes.
Eric Caron
CEO, Co-founder
Eric Caron
CEO, Co-founder
Entrepreneur and Engineer, Medtech / High-tech markets, Novel product development & commercialization, Team building, Fundraising. MBA
Des Regan
CTO, Co-founder
Des Regan
CTO, Co-founder
Medtech Engineer/Entrepr.,
Dir. of Product Development at Nordson Medical, Phillips Medisize and Medtronic, 23 patents, 4 exits
Chris Glover, MD
CMO
Chris Glover, MD
CMO
Interventional Cardiologist,
Dir. Cardiac Catheterization at Ottawa Heart Institute, Professor of Medicine, FRCPC
Robert Orr
CFO
Robert Orr
CFO
Medtech Entrepreneur,
15 yrs CEO of Life360 Innov., formerly 20 yrs consulting tax/M&A at PwC and Deloitte
Contact Us
Contact Us
Locations:
Galway, Ireland
Austin, TX, USA
Page updated
Report abuse